A cell line is a population of cells that can be grown repeatedly in the laboratory, dividing over and over again outside the body they originally came from. Some cell lines have been kept alive for decades, passed from lab to lab around the world, serving as shared workbenches for studying disease, testing drugs, and manufacturing biological therapies. Their importance in biology is hard to overstate: without cell lines, much of modern cancer research, vaccine production, and gene therapy development would stall. But the story behind these endlessly dividing cells involves some surprising biology and more than a few practical headaches.
How Normal Cells Become a Cell Line
When you take cells from a living tissue and place them in a dish, they grow and divide for a while, but they don’t last forever. Normal human cells hit a ceiling after a certain number of divisions, a phenomenon known as the Hayflick limit, driven by the gradual shortening of telomeres, the protective caps on the ends of chromosomes. Each time a cell copies its DNA and splits in two, those caps erode a little more. Eventually the cell stops dividing and enters a state called senescence, essentially retirement at the cellular level.1PubMed Central. Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges
Researchers need cells that bypass this retirement. The process of coaxing cells past their natural limit is called immortalization, and it typically unfolds in two stages. In the first stage, something disrupts the cell’s normal braking system, allowing it to keep dividing past the usual stop point. With viral methods, for instance, a viral protein can disable two of the cell’s key tumor-suppressor proteins (the same ones that normally prevent uncontrolled growth), buying extra rounds of division.2PubMed. SV40-induced immortalization of human cells But after this extended lifespan, most cells still hit a wall called crisis, where the vast majority die. Only a rare handful survive and emerge with the ability to divide indefinitely. These survivors have usually activated telomerase, an enzyme that rebuilds the telomere caps, though roughly a quarter of immortalized cell lines maintain their telomeres through a different, less understood mechanism.3European Journal of Cancer. Telomere dynamics and telomerase activity in in vitro immortalised human cells
Cancer cell lines skip much of this orchestration. Tumor cells have often already disabled their own growth brakes and switched on telomerase, so they arrive in the dish pre-equipped for indefinite growth. That’s why some of the most widely used cell lines in biology, like HeLa cells derived from a cervical tumor in the 1950s, are cancer cells. They didn’t need to be engineered to keep dividing; they were already doing it.
Why Labs Use Cell Lines Instead of Fresh Tissue
Fresh tissue from a donor, known as primary cells, might seem like the most realistic option for lab experiments. But primary cells are difficult to work with. They have a limited lifespan, they vary from one donor to the next, and getting enough of them for large experiments is often impractical. Immortalized cell lines solve these problems. They can be grown in large quantities, used over long periods, and shared between laboratories worldwide. Because every researcher working with a given cell line is working with genetically identical cells, results are easier to compare across experiments and across continents.4PubMed Central. Practical Use of Immortalized Cells in Medicine: Current Advances and Future Perspectives
That reproducibility comes with a trade-off, though. The very genetic changes that make a cell line immortal can also make it behave differently from the tissue it came from. Immortalized lines and cancer lines sometimes respond to drugs or environmental signals in ways that don’t perfectly mirror what happens in the body. Researchers keep this limitation in mind when designing experiments, and newer approaches (discussed later) aim to close that gap.
Cell Lines in Cancer Research and Drug Development
Cancer research is one of the biggest consumers of cell lines. If you want to test whether a new compound kills tumor cells, you need a reliable supply of tumor cells to test it on. Large-scale projects have made this systematic. The Cancer Cell Line Encyclopedia, for example, compiled genetic and drug-response data from nearly a thousand human cancer cell lines across two dozen anticancer drugs, enabling researchers to link specific genetic features of tumors with sensitivity or resistance to particular treatments.5PubMed Central. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity Cross-referencing databases like CellMinerCDB add another layer, letting scientists compare drug activity patterns across multiple independent datasets and look for reproducible biomarkers.6Nucleic Acids Research. CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics
Beyond cancer, high-throughput cell culture technologies use cell lines to screen thousands of chemical compounds rapidly for potential drug candidates, predict toxicity before a drug reaches human trials, and reduce reliance on animal studies.7PubMed Central. Advances in high throughput cell culture technologies for therapeutic screening and biological discovery applications The basic idea is simple: if a compound kills or damages the cells in a dish, it’s probably not safe to put in a person. Cell lines make this kind of screening possible at a scale that would be unthinkable with fresh tissue from donors.
Stem Cell Lines and Disease Modeling
Not all cell lines are immortalized cancer cells or virus-transformed cells. Induced pluripotent stem cells (iPSCs) represent a different breed entirely. These are adult cells, taken from skin or blood, that have been reprogrammed to behave like embryonic stem cells, meaning they can develop into almost any cell type in the body. Researchers can take skin cells from a patient with a liver disease, reprogram them into iPSCs, and then coax those iPSCs into becoming liver cells in a dish, creating a disease model that carries the patient’s own genetic makeup.8PubMed Central. Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease
This approach opens up possibilities that traditional cell lines can’t match. You can study how a disease unfolds at the cellular level in cells from the actual patient, screen drugs against those patient-specific cells, and even explore gene therapy approaches tailored to a particular genetic mutation. The technology is still maturing, and growing iPSC-derived cells reliably takes more skill and expense than maintaining a standard cancer cell line, but it’s reshaping how researchers think about personalized medicine.
Manufacturing Medicines at Scale
Cell lines don’t just help discover drugs; they produce them. Many of the biologic drugs on the market today, antibodies used to treat cancer, autoimmune diseases, and other conditions, are manufactured inside living cells grown in massive bioreactors. Chinese hamster ovary (CHO) cells are the workhorse of this industry. They grow well, they can be engineered to produce human proteins with the right chemical modifications, and decades of manufacturing experience have established reliable quality standards around them.9Scientific Reports. Development of a stable antibody production system utilizing an Hspa5 promoter in CHO cells
One ongoing challenge in biomanufacturing is keeping the engineered cells productive over the course of a long production run. Cells can gradually reduce their output of the desired protein as the culture ages. Researchers address this by engineering better gene-expression systems, such as promoters that maintain protein production even in the later stages of a culture batch. The economics here are significant: a single batch of antibody drug produced in a bioreactor can be worth millions of dollars, so even small improvements in cell-line productivity translate into large gains.
Cell Lines Beyond Mammals
The term “cell line” is not limited to human or rodent cells. Insect cell lines, particularly those derived from the fall armyworm (Spodoptera frugiperda), are widely used for producing complex proteins that are difficult to make in bacteria. The Sf9 and Sf21 lines are popular because they’re cost-effective and compatible with baculovirus expression systems, which can churn out large amounts of recombinant protein.10PubMed Central. A beginners guide to Sf9 and Sf21 insect cell line culture and troubleshooting Fish cell lines, plant cell lines, and others serve niche but important roles in virology, environmental toxicology, and agricultural science. The underlying principle is the same: take cells from an organism, establish them in culture so they keep dividing, and use them as a controlled system to study biology or manufacture useful molecules.
The Contamination Problem
One of the most persistent and embarrassing problems in cell-line research is contamination. There are two major flavors: mix-ups between cell lines and infection by microorganisms.
Cell-line mix-ups happen more often than most researchers would like to admit. Cells from one line can quietly overtake another if even a tiny cross-contamination event occurs in the lab, and the faster-growing impostor may completely replace the original line within a few passages. A study examining 278 cell lines from 28 Chinese research institutes found that about 46% were cross-contaminated or misidentified.11PLOS ONE. Investigation of Cross-Contamination and Misidentification of 278 Widely Used Tumor Cell Lines Another analysis of 482 human tumor cell lines found roughly 96 were misidentified based on short tandem repeat (STR) profiling, and even among the lines that passed STR testing, a few were contaminated with cells from other species entirely.12Scientific Reports. A Combination of Species Identification and STR Profiling Identifies Cross-contaminated Cells from 482 Human Tumor Cell Lines STR profiling, a DNA fingerprinting technique, is the standard method for verifying that a cell line is what it claims to be.13PubMed Central. Short tandem repeat profiling via next-generation sequencing for cell line authentication But as those studies show, it’s not foolproof on its own, and many labs still don’t test as often as they should.
Mycoplasma, a type of tiny bacterium that lacks a cell wall, is the other major contaminant. Mycoplasma infections don’t typically kill the host cells, which is part of why they’re so insidious. Cells look fine under the microscope, but mycoplasma can alter cell growth, metabolism, and even chromosomal stability, skewing experimental results in ways that are hard to trace.14PubMed Central. Prevention, Diagnosis and Eradication of Mycoplasma Contamination in Cell Culture The range of effects is essentially limitless, touching everything from gene expression to how cells respond to drugs.15PubMed Central. Mycoplasma contamination of cell cultures: Incidence, sources, effects, detection, elimination, prevention Routine testing with PCR-based assays and strict aseptic technique are the standard defenses, but mycoplasma remains a persistent headache.
Genetic Drift and Why Passage Number Matters
Even a perfectly authenticated, mycoplasma-free cell line isn’t static. Every time cells are split and transferred to a fresh dish, an event called a “passage,” they accumulate small genetic and epigenetic changes. Over many passages, a cell line can drift away from its original characteristics. Low-passage cancer cell lines generally resemble the original tumor more closely, while prolonged culture can alter gene expression, drug sensitivity, DNA methylation, and metabolic profiles.16PubMed. Passage number of cancer cell lines: Importance, intricacies, and way-forward
The pattern of this drift isn’t always a steady, linear slide. RNA sequencing of tumor cell lines across passages revealed that mid-passage cells sometimes showed more dramatic shifts in gene activity related to cell cycle and metabolism, while very early and very late passages could look surprisingly similar to each other.17PubMed Central. Cell passage number drives transcriptomic drift as an overlooked factor in experimental reproducibility Work in non-mammalian cells has found a similar nonlinear pattern, with young and mid-aged cells clustering with very old cells on some measures while diverging on others.18PubMed. Aging Cell Culture – Genetic and Metabolic Effects of Passage Number on Zebrafish Z3 Cells The practical takeaway for researchers is that passage number should be tracked and reported in publications, because two labs working with the “same” cell line at very different passage numbers may get meaningfully different results.
CRISPR and Custom-Built Cell Lines
Gene-editing tools, especially CRISPR-Cas9, have transformed how researchers use cell lines. Rather than simply working with whatever genetic hand a cell line was dealt, scientists can now delete, modify, or insert specific genes with relative precision. A single cell carrying the desired edit can be expanded into a new clonal cell line, creating a tool for exploring what a specific protein does, what happens when a gene is lost, or whether a particular mutation drives drug resistance.19PubMed Central. Generating Single Cell-Derived Knockout Clones in Mammalian Cells with CRISPR/Cas9
The technology keeps getting more flexible. Methods now exist to knock out multiple genes at once in a single experiment, such as disrupting three separate genes simultaneously in CHO cells used for drug manufacturing.20PubMed. One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment Simplified approaches have also been developed for cancer cell lines, making it easier to delete large stretches of DNA without the laborious process of building custom targeting constructs for every experiment.21Scientific Reports. A simple method using CRISPR-Cas9 to knock-out genes in murine cancerous cell lines The combination of stable cell lines and precise gene editing has become one of the most powerful setups in modern biology for asking cause-and-effect questions about genes.
From Flat Dishes to Three-Dimensional Models
Traditional cell culture grows cells in a single flat layer on the bottom of a plastic dish. This two-dimensional setup has been the default for generations and is still the backbone of basic research. But flat cultures have obvious shortcomings: cells in the body don’t grow in monolayers. They exist in three-dimensional tissues surrounded by other cell types, extracellular scaffolding, and complex chemical gradients. Growing cells on a flat surface can change their shape, polarity, and the way they interact with their environment, which sometimes makes them poor stand-ins for living tissue.22PubMed Central. 2D and 3D cell cultures – a comparison of different types of cancer cell cultures
Three-dimensional culture methods aim to close this gap. Cells can be grown into spheroids (small clusters that self-organize into ball-like structures), organoids (miniature organ-like structures derived from stem cells), or bioprinted constructs layered by machine into defined architectures.23PubMed Central. Beyond monolayers: a comparative analysis of 2D cell cultures and 3D in vitro models as new approach methodologies These 3D models better mimic how cells behave in the body and often respond to drugs more realistically than flat cultures.24PubMed Central. Modeling Physiological Events in 2D vs. 3D Cell Culture The shift toward 3D culture is also being driven by ethical pressure to reduce reliance on animal testing; better in vitro models mean fewer animals are needed to predict how a drug will behave in a human body.
Organ-on-chip devices push this further by growing cell lines inside microfluidic channels that mimic blood flow and the physical forces cells experience inside organs. Immortalized cell lines and cancer cell lines are commonly used in these systems because they’re easy to obtain and handle, even though they don’t perfectly replicate normal tissue behavior.25Cell Reports Methods. What Is a Cell Line and Why Is It Important in Biology? – Section: Cell sources and types Primary cells and iPSC-derived cells are increasingly being introduced into these platforms for higher physiological fidelity, though at greater cost and complexity.
Freezing, Banking, and Sharing Cell Lines
Cell lines would be far less useful if they could only exist as actively growing cultures. The ability to freeze cells and revive them later is what makes global sharing and long-term storage possible. Cryopreservation typically involves cooling cells slowly, at about one degree Celsius per minute, in a medium containing a cryoprotectant like DMSO that prevents ice crystals from destroying cell membranes.26British Journal of Cancer. Guidelines for the use of cell lines in biomedical research Controlled-rate freezers give the most consistent results, though simpler methods using insulated containers in a standard freezer work for routine banking.27PubMed. Cryopreservation of animal and human cell lines
Stored cell stocks need to be kept below minus 130 degrees Celsius for long-term viability. At minus 80, cells can lose viability within months. Liquid nitrogen storage tanks, which maintain temperatures around minus 196 degrees, are the gold standard. Every time a new batch is frozen, best practice calls for immediately thawing one vial back out to confirm the cells survived.26British Journal of Cancer. Guidelines for the use of cell lines in biomedical research Biobanks like the American Type Culture Collection (ATCC) and the German Collection of Microorganisms and Cell Cultures (DSMZ) serve as centralized repositories, storing authenticated cell lines and distributing them to researchers worldwide. These repositories are the infrastructure that keeps cell-line research reproducible across decades and across borders.
Good Cell Culture Practice and Reproducibility
The problems of contamination, misidentification, and genetic drift have pushed the scientific community toward formal standards for how cell lines should be handled. The concept of Good Cell Culture Practice (GCCP) parallels the Good Manufacturing Practice (GMP) standards used in pharmaceutical production, adapted for the academic research setting.28Toxicology in Vitro. Good cell culture practices & in vitro toxicology In practice, these principles include authenticating cell lines by STR profiling when they arrive in the lab and again before publishing results, testing for mycoplasma at regular intervals, recording passage numbers, and maintaining detailed documentation of culture conditions.
Adoption has been uneven. Many journals now require proof of cell-line authentication before publishing studies, which has helped, but plenty of labs, especially in academic settings where training and oversight vary widely, still cut corners. The stakes are real: a study built on a misidentified cell line can waste years of effort and research funding, and any conclusions drawn from it are unreliable from the start.
Who Owns a Cell Line
When cells are taken from a person and turned into a commercially valuable cell line, thorny questions arise about consent, ownership, and profit-sharing. The most famous case involved HeLa cells, taken from Henrietta Lacks without her knowledge or consent in 1951, which went on to become one of the most widely used cell lines in history. That case helped spark broader discussions about the rights of tissue donors. Today, ethical frameworks emphasize informed consent, but the specifics remain complicated. Questions about whether a donor retains any property interest in cells after they leave the body, and whether they’re entitled to a share of commercial profits, remain unresolved in many jurisdictions.29PubMed Central. Ethical and legal considerations regarding the ownership and commercial use of human biological materials and their derivatives
Some countries have moved toward stronger donor protections, requiring explicit consent for commercial use and establishing governance frameworks for biobanks. Others still operate under older legal doctrines that treat excised tissue as abandoned property once it leaves the patient. For researchers, the practical guidance is straightforward: document consent clearly, follow institutional review board requirements, and be transparent about intended uses. But the broader ethical conversation is far from settled, and it has only grown more complex as cell lines become more commercially valuable and as gene-editing tools make it easier to derive entirely new lines from existing material.